(Q39578418)

13 September 2017

title

Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997. (English)

1 reference

13 September 2017

1 reference

Lee MS

1

1 reference

13 September 2017

Chien LJ

series ordinal

2

1 reference

13 September 2017

Yueh YY

series ordinal

3

1 reference

13 September 2017

Lu CF

series ordinal

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

13 September 2017

1 reference

13 September 2017

volume

19

1 reference

13 September 2017

issue

32

1 reference

13 September 2017

page(s)

4644-4651

1 reference

Seroepidemiology and evaluation of passive surveillance during 1988-1989 measles outbreak in Taiwan

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Epidemiology of measles in Taiwan: dynamics of transmission and timeliness of reporting during an epidemic in 1988-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Post mass-immunization measles outbreak in Taoyuan County, Taiwan: dynamics of transmission, vaccine effectiveness, and herd immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Protective titres of measles neutralising antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

The 1st International Standard for anti-measles serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

An evaluation of nine commercial EIA kits for the detection of measles specific IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Further-attenuated measles vaccine: characteristics and use.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Measles antibody levels in a vaccinated population in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Measles immunity and vaccination policy in Catalonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Persistence of Measles Antibody after Revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Response to measles revaccination among Bolivian school-aged children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after Revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Timing and effectiveness of requirements for a second dose of measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Protection after two doses of measles vaccine is independent of interval between doses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900239-0

7 January 2021

10.1016/S0264-410X(01)00239-0

Identifiers

DOI

1 reference

13 September 2017

1 reference